Kaitlyn E. Brock

Jul 25, 2023 | mdpi.com | Robin Cooper |R. L |Kaitlyn E. Brock

Abstract: Simple SummaryThe actions of bacterial toxin lipopolysaccharides (LPS) can lead to the development of illness in humans and animals by triggering an immune system response. LPS is known to negatively affect ion channels within mammalian cells and block receptors in flies. There are currently no pharmacological blockers for LPS. In recent studies, the compound doxapram has been shown to block some of the negative effects of LPS.